Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 2, 2011, Pages 91-94

  Rodier, Patricia ^a   Miller, Richard K ^a   Brent, Robert L ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TERBUTALINE;

ASTHMA; AUTISM; BRAIN REGION; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DRUG CLEARANCE; HUMAN; LANGUAGE DEVELOPMENT; NOTE; OUTCOME ASSESSMENT; PERINATAL DRUG EXPOSURE; PREMATURE LABOR; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RISK FACTOR; TERATOGENICITY;

EID: 79551495844     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.11.030     Document Type: Editorial

References (34)

1. F.R. Witter, A.W. Zimmerman, J.P. Reichmann, and S.L. Connors In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes Am J Obstet Gynecol 201 2009 553 559
2. S. Chakrabarti, and E. Fombonne Pervasive developmental disorders in preschool children: confirmation of high prevalence Am J Psychiatry 162 2005 1133 1141
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders (IV) 1994 American Psychiatric Association Washington, DC
4. A. Bailey, A. Le Couteu, and I. Gottesman Autism as a strongly genetic disorder: evidence from a British twin study Psych Med 25 1995 63 77
5. D.H. Geshwind Advances in autism Annu Rev Med 60 2009 367 380
6. S. Jamain, H. Quach, and C. Betancur Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism Nat Genet 34 2003 27 29
7. C.M. Durand, C. Betancur, and Boeckers Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders Nat Genet 39 2007 25 27
8. A. Le Couteur, A. Bailey, and S. Goode A broader phenotype of autism: the clinical spectrum in twins J Psychol Psychiatry 37 1996 785 801
9. Autism Genome Project Consortium (AGPC) Mapping autism risk loci using genetic linkage and chromosomal rearrangements Nat Genet 39 2007 319 328
10. J. Sebat, B. Lakshmi, and D. Malhotra Strong association of de novo copy number mutations with autism Science 316 2007 445 449
11. T.L. Arndt, C.J. Stodgell, and P.M. Rodier The teratology of autism Int J Devel Neurosci 23 2005 189 199
12. M.T. Stein, S. Parker, J. Coplan, and H. Feldman Expressive language delay in a toddler Pediatrics 107 2001 905 909
13. S.L. Connors, D.E. Crowell, and C.G. Eberhart Beta 2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins J Child Neurol 20 2005 876 884
14. Thrasher JD, Kilburn KY, Immers IB. Autism, terbutaline and neurological impairment: Ramazzi days 2007: 25th Anniversary Jubilee, Capri Italy.
15. K.H. Kilburn, J.D. Thrasher, and N.B. Immers Do terbutaline and mold-associated impairments of the brain and lung relate to autism? Toxicol Ind Health 25 2009 703 710
16. L.A. Croen, J.K. Grether, C.K. Yoshida, R. Odouli, and J. Van de Water Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study Arch Pediatr Adolesc Med 159 2005 151 157
17. L. Croen, S.L. Connors, M. Matevia, C. Newschaffer, and A.W. Zimmerman Prenatal exposure to beta-2- adrenergic agonists and risk of autism spectrum disorders http://imfar.confex.com/2009/webprogram/Paper3971.html 2009 Accessed Oct. 10, 2009
18. J.R. Aldridge, A. Meyer, F.J. Seidler, and T.A. Slotkin Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on sertonergic systems in neonatal rat brain regions Tox Appl Pharm 203 2005 132 144
19. K. Tegner, H.T. Nilsson, C.G.A. Persson, K. Persson, and A. Ryrfeldt Elimination pathways of terbutaline Eur J Respir Dis 134 1984 93 100
20. G. Ginsberg, D. Hattis, R.K. Miller, and B. Sonawane Pediatric pharmacokinetic data: implications for environmental risk assessment for children Pediatrics 113 2004 973 983
21. M.C. Rhodes, F.J. Seidler, and A. Abdel-Rahman Terbutaline is a neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex J Pharmacol Exp Ther 308 2004 529 537
22. T.L. Kemper, and M. Bauman Neuropathology of infantile autism J Neuropathol Exp Neurol 57 1998 645 652
23. A. Bailey, P. Luthert, and A. Dean A clinicopathological study of autism Brain 121 1998 889 905
24. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo Neuroglial activation and neuroinflammation in the brain of patients with autism Ann Neurol 57 2005 67 81
25. M.C. Zerrate, M. Pletnikov, and S.L. Connors Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism J Pharmacol Exp Ther 322 2007 16 22
26. G.M. McAlonan, E. Daly, and V. Kumari Brain anatomy and sensorimotor gating in Asperger's syndrome Brain 127 2002 1594 1606
27. W. Perry, A. Minassian, B. Lopez, L. Maron, and A. Lincoln Sensorimotor gating deficits in adults with autism Biol Psychiatry 61 2007 482 486
28. T. Schneider, and R. Przewlocki Behavioral alterations in rats prenatally exposed to valproic acid Neuropsychopharmacology 30 2005 80 89
29. D.F. MacKay, G.C.S. Smith, R. Dobbie, and J.P. Pell Gestational age at delivery and special educational need: retrospective cohort study of 407,503 schoolchildren PLoS Med 7 2010 e1000289
30. S. Buckmayer, S. Johansson, A. Johansson, C.H. Hultman, P. Sparen, and S. Cnattingius Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics 124 2009 e817 e825
31. M. Pitzer, M.H. Schmidt, G. Esser, and M. Laucht Child development after maternal tocolysis with beta-sympathomimetic drugs Child Psychiatry Hum Dev 31 2001 165 182
32. B. Bergman, H. Bokstrom, O. Borgas, L. Enk, T. Hedner, and B. Wangberg Transfer of terbutaline across the human placenta in late pregnancy Obstet Gynecol Surv 40 1985 69 71
33. F. Lam, J. Elliott, and J.S. Jones Clinical issues surrounding the use of terbutaline sulfate for preterm labor Obstet Gynecol Surv 53 1998 585 595
34. R.L. Goldenberg The management of preterm labor Obstet Gynecol 100 2002 1020 1037